Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03834519
Brief Title: Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010) (KEYLYNK-010)

First Submitted : February 6, 2019
First Submitted that Met QC Criteria : February 6, 2019
First Posted : February 8, 2019

Last Update Submitted that Met QC Criteria : May 13, 2022
Last Update Posted : May 20, 2022